Candriam SCA’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $46.4M | Sell |
|
|||||
|
2025
Q1 | $66.8M | Sell |
|
|||||
|
2024
Q4 | $85.2M | Buy |
|
|||||
|
2024
Q3 | $42M | Buy |
|
|||||
|
2024
Q2 | $28.7M | Sell |
|
|||||
|
2024
Q1 | $39.6M | Buy |
|
|||||
|
2023
Q4 | $30.7M | Buy |
|
|||||
|
2023
Q3 | $23.9M | Sell |
|
|||||
|
2023
Q2 | $33.2M | Sell |
|
|||||
|
2023
Q1 | $56.6M | Buy |
|
|||||
|
2022
Q4 | $55.1M | Buy |
|
|||||
|
2022
Q3 | $31.4M | Buy |
|
|||||
|
2022
Q2 | $20.9M | Sell |
|
|||||
|
2022
Q1 | $20.3M | Sell |
|
|||||
|
2021
Q4 | $19.2M | Sell |
|
|||||
|
2021
Q3 | $22.5M | Sell |
|
|||||
|
2021
Q2 | $26.7M | Sell |
|
|||||
|
2021
Q1 | $106M | Sell |
|
|||||
|
2020
Q4 | $111M | Buy |
|
|||||
|
2020
Q3 | $102M | Buy |
|
|||||
|
2020
Q2 | $88.5M | Sell |
|
|||||
|
2020
Q1 | $157M | Buy |
|
|||||
|
2019
Q4 | $160M | Sell |
|
|||||
|
2019
Q3 | $133M | Buy |
|
|||||
|
2019
Q2 | $110M | Buy |
|
|||||
|
2019
Q1 | $94.1M | Buy |
|
|||||
|
2018
Q4 | $70.8M | Buy |
|
|||||
|
2018
Q3 | $63.7M | Buy |
|
|||||
|
2018
Q2 | $53M | Buy |
|
|||||
|
2018
Q1 | $26.3M | Sell |
|
|||||
|
2017
Q4 | $27.3M | Sell |
|
|||||
|
2017
Q3 | $39.7M | Buy |
|
|||||
|
2017
Q2 | $13.6M | Sell |
|
|||||
|
2017
Q1 | $15.5M | Sell |
|
|||||
|
2016
Q4 | $26.9M | Sell |
|
|||||
|
2016
Q3 | $29.3M | Buy |
|
|||||
|
2016
Q2 | $29.3M | Sell |
|
|||||
|
2016
Q1 | $27.1M | Buy |
|
|||||
|
2015
Q4 | $16.3M | Buy |
|
|||||
|
2015
Q3 | $10.5M | Sell |
|
|||||
|
2015
Q2 | $22.4M | Sell |
|
|||||
|
2015
Q1 | $46.3M | Buy |
|
|||||
|
2014
Q4 | $22.7M | Buy |
|